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ReviewNuclear Hormone Receptors
in T Lymphocytes
appropriate interaction of their T cell antigen receptor
(TCR) with major histocompatibility complex (MHC) mol-
ecules loaded with endogenous peptide antigens (posi-
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tive selection) (Jameson et al., 1995). More than 95% ofUniversity of California, Berkeley
immature double-positive (DP, CD4CD8) thymocytesBerkeley, California 94720
undergo apoptosis. Most of these cells die by a process2 Howard Hughes Medical Institute
known as “death by neglect,” due to sub-threshold orSkirball Institute of Biomolecular Medicine
absent interaction of the TCR with host MHC/peptideNew York University School of Medicine
complexes present on the thymic stromal cells. The sig-540 First Avenue
naling pathways involved in this form of apoptosis areNew York, New York 10016
poorly understood, and it remains unclear if their initia-
tion is cell autonomous or triggered by extracellular fac-
tors. A small proportion of thymocytes undergo apopto-Among the numerous steroid and orphan nuclear re-
sis triggered by high avidity interaction of the TCR withceptors encoded within mammalian genomes, several
host MHC/peptide complexes, a process that purgesare involved in regulating immune system functions.
the T cell repertoire of many potentially harmful self-We review here recent studies on the glucocorticoid
reactive cells. The signaling events in this process,receptor and the orphan receptors Nur77 and ROR.
known as negative selection, are also poorly under-These molecules play key roles in the development
stood, but require intact TCR-associated signaling com-and the effector functions of T lymphocytes.
plexes. All nuclear receptors that will be discussed here
have been implicated in regulation of thymocyte andIntroduction
T cell apoptosis. Nur77 and the related Nor-1 proteinSteroid hormones have long been known to have a pro-
are proapoptotic factors that appear to have key rolesfound influence on the immune system. Their adminis-
in negative selection during development (Zhang et al.,tration results in apoptosis of immature thymocytes and
1999). In experimental models, GR can also be shownalso in general immunosuppression characterized by
to have proapoptotic activity, and clearly mediates corti-compromised activation of antigen-specific lympho-
costeroid-induced apoptosis in thymocytes, but itscytes, reduced cytokine production, and impaired func-
function under normal developmental and homeostatiction of antigen-presenting cells. Resection of the adre-
conditions remains unclear. Whether GR is involved innals, the principal site for biosynthesis and systemic
promoting death by neglect or in setting the thresholdrelease of corticosteroids, results in thymic hyperplasia.
for TCR-mediated selection signals has been a subjectThese and other observations have led to the proposal
of considerable controversy, fueled most recently bythat endogenous corticosteroids, through interaction
studies with mutant mice that have altered or absent GRwith the glucocorticoid receptor (GR), a ligand-depen-
function (reviewed in Godfrey et al., 2001). In contrast,dent transcription factor, have a key role in the selection
ROR has antiapoptotic function in thymocytes and hasof T cells during their development in the thymus (Ash-
been postulated to prevent premature death by count-well et al., 2000). The role of GR and of its ligands in the
ering constitutively active pathways that favor apoptosisdevelopment and function of the immune system has
(Littman et al., 1999).received much attention because of the therapeutic
The biochemical basis for nuclear receptor activityvalue of cortisone and related synthetic steroids in treat-
has been elucidated for several ligand-dependent fac-
ment of inflammation and malignancies. In recent years,
tors. The receptors reside in either the cytoplasm or
several other steroid and non-steroid nuclear receptors
nucleus, and are activated upon binding of ligand to
have been shown to also have key functions in the devel- their C-terminal ligand-binding domain (LBD). They then
opment of the immune system, in shaping of the T cell bind to DNA as monomers, homodimers, or heterodi-
repertoire, and in regulation of inflammatory responses. mers in conjunction with other proteins (Tzameli and
These include the vitamin D receptor, estrogen receptor, Moore, 2001; Weatherman et al., 1999). Steroid recep-
retinoic acid receptors (RAR), peroxisome proliferator- tors, including GR, are often bound to cytoplasmic chap-
activated receptors (PPAR), and several orphan recep- erones, and are subsequently released for transport to
tors that have no reported ligands (Alroy et al., 1995; the nucleus upon binding of ligand (Pratt, 1997). Binding
Bissonnette et al., 1995; Moore et al., 2001; Staples et of ligand typically results in a conformational change
al., 1999). In this review, we will focus on the function that allows the LBD to interact with coactivators that
in T cells of GR and several orphan nuclear receptors, have histone acetyltransferase activity, including mem-
members of the Nur77 family and ROR, with a particular bers of the p160 and p300/CBP families (Glass and Ro-
emphasis on their proposed diverse roles in the selec- senfeld, 2000; Weatherman et al., 1999). In the absence
tion of the T cell repertoire. of ligand, DNA-bound nuclear receptors may fail to form
To survive differentiation in the thymus and be ex- active dimers, and/or they may be complexed with core-
ported to peripheral lymphoid organs, T cells must have pressor molecules, which in turn interact with histone
deacetylases to repress transcription (Glass and Rosen-
feld, 2000). In some cases, binding of ligand can interfere3 Correspondence: littman@saturn.med.nyu.edu (D.R.L.). winoto@
uclink4.berkeley.edu (A.W.) with recruitment of coactivators, and hence different
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ligands may either activate or inhibit the transcription fied, but it is known that caspase-9 is activated during
this process. In mice lacking caspase-9, dexametha-of target genes under the direction of nuclear receptors
sone-induced thymocyte apoptosis was significantly(Tzameli and Moore, 2001). Production of ligand by cells
impaired, which suggests that steroids activate the mi-within the microenvironment of the target cell can there-
tochondrial apoptotic pathway (Kuida et al., 1998). Con-fore influence the expression of genes regulated by nu-
sistent with this finding, dexamethasone-induced apo-clear receptors. However, for some orphan nuclear re-
ptosis was significantly reduced in transgenic miceceptors, like Nur77 and ROR, it is not clear if
expressing elevated levels of Bcl-2 or Bcl-xL in thymo-physiologically relevant ligands exist. The transcrip-
cytes (Chao et al., 1995). Treatment of thymocytes withtional activities of these proteins can be detected imme-
glucocorticoids also results in a reduced level of the celldiately following their expression, suggesting that their
cycle inhibitor p27kip1, and consequently in increasedligands might exist constitutively inside the cells or in
entry of cells into S phase (Gil-Gomez et al., 1998) (Figureserum or that they do not require ligand. Alternatively,
1). Because inhibition of cyclin-dependent kinasesthese nuclear receptors may be modulated by ligands
blocks thymocyte apoptosis, it has been proposed thatacting through receptor partners that form hetero-
cell cycle progression, in addition to the activation ofdimers.
caspases, is required for thymocyte apoptosis. Indeed,
Bcl-2 and Bcl-xL can also block cell cycle progressionThe Role of Glucocorticoid Receptor
by increasing levels of p27kip1, through a mechanismin the Immune System
that has not yet been elucidated. These antiapoptoticGlucocorticoids are commonly used as antiinflamma-
proteins may hence protect thymocytes from glucocorti-tory and immunosuppressive drugs. In the body, they
coid-induced apoptosis by inhibiting the mitochondrialare produced by the adrenal gland and bind to the gluco-
cell death pathway and by blocking cell cycle progres-corticoid receptor, one of the earliest identified mem-
sion (Figure 1).bers of the steroid receptor family. In contrast to ROR
While GR clearly plays an important role in mouseand Nur77, which are mainly found in the nucleus, GR
development, its role in lymphocyte development re-is held in the cytoplasm by heat shock proteins such as
mains controversial (Godfrey et al., 2001; Jondal et al.,hsp70 and hsp90 (Pratt, 1997). Glucocorticoids cause
2001). Although administration of glucocorticoids re-a conformational change in the receptor, causing it to
sults in apoptosis of immature thymocytes, but not ma-translocate to the nucleus where it exerts its function.
ture T cells, it is unclear whether endogenous corticoste-GR binds as a homodimer to a DNA motif termed a
roids have roles in normal T cell development in additionglucocorticoid responsive element (GRE) and transacti-
to their well-documented roles in responses to stress.vates GRE-regulated genes. In addition to its transcrip-
Induction of thymocyte apoptosis by TCR ligation istional activities, GR can also exert negative influence
inhibited by glucocorticoids (Ashwell et al., 2000) and,by heterodimerizing and interfering with the activities of
conversely, glucocorticoid-induced apoptosis can betranscription factors like AP-1, NF-B, CREB, and
inhibited by TCR-mediated activation of the ERK signal-GATA-1. Thus, GR possesses two functions, one as a
ing pathway (Jamieson and Yamamoto, 2000). Based
ligand-dependent transcription activating factor and the
on these findings of mutual inhibition, Ashwell and col-
other as a ligand-dependent negative regulator of other
leagues have proposed that endogenous corticoste-
transcription factors. The latter function is in most cases
roids may regulate the thresholds for TCR-mediated
independent of DNA recognition by GR, and the recep- positive and negative selection of thymocytes (Ashwell
tor’s zinc finger DNA binding domain is dispensable et al., 2000). They found that corticosteroids are pro-
(Herrlich, 2001). duced by nonlymphoid cells in the thymus, and that
The function of GR in vivo has been assessed in sev- blockade of glucocorticoid function in thymocytes, us-
eral mouse lines bearing targeted mutations at the GR ing either pharmacological agents or an antisense GR
locus. GR-deficient mice died in the first minutes after transgene, reduced the number of DP thymocytes and
birth, due to defective lung development (Cole et al., altered the T cell repertoire. In addition, T cells that
1995). These mice also exhibited defective skin matura- normally undergo positive selection were found to un-
tion, impaired erythrocyte progenitor proliferation, and dergo apoptosis, presumably because the normally
other defects, suggesting that glucocorticoids are im- weak positive selection signals become strong ones
portant for several aspects of mouse development. In- (negative selection) when the inhibitory effect of GR is
terestingly, mice with a knockin mutation in the GR lo- reduced in these cells (Ashwell et al., 2000). However,
cus, which resulted in a dimerization-defective GR that the role of GR in normal T cell development has been
was largely inactive for GRE-mediated transcription challenged by several recent findings. First, the specific-
(termed GRdim/dim), survived to adulthood with no appar- ity of the antisense approach may be a problem, as
ent developmental defects, suggesting that the DNA another group reported an increase in the number of
binding function of GR is not required for early stages thymocytes in an independently derived transgenic line
of mouse development (Reichardt et al., 1998). However, using the same promoter (lck proximal promoter) (Jondal
thymocytes from these mice were completely resistant et al., 2001). More importantly, total thymocyte cell num-
to glucocorticoid-induced cell death. These data sug- bers and the CD4CD8 and CD4CD8 subsets have
gest that the transcriptional activity of GR is required been shown to be normal in GR/ animals and in
to sensitize thymocytes to glucocorticoids, but that this GRdim/dim mice (Cole et al., 1995; Reichardt et al., 1998).
activity may not be required for survival of the mouse. Recently, T cell development in fetal thymus was exam-
The targets for GR-mediated transcription during ste- ined in GR/ embryos (Purton et al., 2000). T cell sub-
sets and cell numbers, as well as their ability to undergoroid-induced thymocyte apoptosis remain to be identi-
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Figure 1. Proposed Mechanism of Action of
Glucocorticoids and ROR in Regulating
Apoptosis of Double Positive Thymocytes
negative selection in response to anti-CD3/CD28 or su- enhanced susceptibility of thymocytes to steroids, but
also increased resistance to lipopolysaccharide-perantigens were found to be largely normal. GR/ thy-
mocytes were completely resistant to glucocorticoid- induced septic shock (Reichardt et al., 2000). This result
suggests that endogenous glucocorticoids normallymediated apoptosis, precluding the possible existence
of another receptor with redundant function. These data play a role in limiting inflammation. Interestingly, in
GRdim/dim mice, glucocorticoids were effective in limitingcast doubt as to the function of GR during normal T cell
development, at least during fetal stages. However, it inflammatory responses, which includes activation of
NF-B, suggesting that GRE binding and activation ofremains possible that these conflicting results reflect
differences in the strains of mice used or the effects genes by GR are not required for its immunosuppressive
functions and activation of IB transcription (Reichardtexerted by the mutations or pharmacologic agents such
as RU486 on cells other than thymocytes. It is also possi- et al., 2001). Further studies are needed to determine the
direct target genes that provide GR-mediated protectionble that in mice with dimerization-defective GR, gluco-
corticoids can still exert a developmental function in from inflammatory damage and to identify the cells in-
volved in this process.thymocytes unrelated to induction of apoptosis by GR
target genes, but perhaps mediated by GR monomer in
association with other transcription factors. Additional The Orphan Nuclear Receptor ROR
The orphan nuclear receptor ROR (also called TOR,experiments, preferably with mice harboring thymocyte-
specific mutations in GR, to eliminate possible effects RZRG, Thor, or NR1F3) was identified by virtue of its
homology to RAR, and its mRNA was shown to be mostin other cells, will need to be performed. Use of such
mice to study negative selection and the role of TCR abundantly expressed in the double-positive (CD4CD8)
cells in thymus (Hirose et al., 1994; Ortiz et al., 1995).signaling will then help to settle the question of whether
GR and glucocorticoids do play a central role in T cell Subsequent studies revealed the predominant gene
product in the thymus to be a closely related isoform,development, particularly after the fetal stages.
In addition to their activity in thymocytes, glucocorti- RORt, generated by use of an alternative promoter
within the second exon of the ROR gene (resulting incoids appear to have important functions in activation
of the innate immune system and in antigen presentation a protein lacking the N-terminal 24 residues of ROR)
(He et al., 1998). RORt was isolated using expression(Moser et al., 1995). These effects likely account for the
powerful anti-inflammatory effects of steroids. Although cloning aimed at identifying genes that inhibit activation-
induced cell death (AICD) in a T cell hybridoma, but toprecise understanding of the mechanisms of immuno-
suppressive action of glucocorticoids is lacking, it is date there has been no discernable difference in func-
tion between ROR and RORt. Forced expression ofwell established that ligand-dependent inhibition by GR
of various transcription factors attenuates expression either isoform in T cell lines and hybridomas inhibited
expression of IL-2 and Fas ligand, resulting in inhibitionof inflammatory cytokines, which may result in skewing
of the immune response (Herrlich, 2001; Vieira et al., of both TCR-induced cell proliferation and cell death
(He et al., 1998; Littman et al., 1999). ROR inhibits1998). In addition, GR can activate transcription of IB,
which then serves to limit the function of NF-B, a key NFAT-regulated transcription, which is required for
TCR-mediated activation of both the FasL and IL-2transcriptional activator in both innate and adaptive im-
mune responses (Auphan et al., 1995; Scheinman et al., genes. ROR binds to the NFAT binding motif in the IL-2
enhancer, and thus competes with NFAT for binding to1995). Mice in which expression of GR was increased
after introduction of a BAC transgene displayed not only DNA (Littman et al., 1999). In response to its ligand,
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vitamin D3 receptor (VDR) has similarly been shown to companied by entry of cells into S phase, is an obligate
step in programming cells for apoptosis (Gil-Gomez etbind to the composite NFAT/AP-1 sites in the IL-2 and
GM-CSF enhancers, thus explaining vitamin D3-induced al., 1998). However, these studies relied on inducing
apoptosis with corticosteroids, and it is unclear if physi-transcriptional repression and inhibition of T cell prolifer-
ation (Alroy et al., 1995). Glucocorticoid activation of ological signals for inducing cell death (which are yet
to be characterized) similarly require G1 to S phaseGR and retinoid activation of retinoid X receptor (RXR)-
containing nuclear receptors have also been reported progression. In mice that lack expression of p27kip1, de-
spite an increase in thymic cellularity and in S phaseto inhibit FasL induction in T cells (Yang et al., 1995).
Whether the transcriptional repression activity of ROR progression, there was no evidence of increased thymo-
cyte apoptosis (Fero et al., 1996). It is thus possible thatalso requires binding of a ligand or formation of a hetero-
dimer is not yet known. Whereas VDR forms a hetero- Bcl-xL regulates survival of double-positive thymocytes
both by maintaining a sufficiently high level of p27kip1dimer with RXR to mediate transcriptional activation
upon binding to vitamin D3 responsive elements, it has and by inhibiting mitochondria-dependent activation of
the apoptotic pathway by proapoptotic members of thebeen shown to repress transcription by binding as a
monomer to the NFAT/AP-1 site. In the latter case, VDR Bcl-2 family (Figure 1). Abrogation of both functions
would then be required to observe premature apoptosismonomer blocks binding of NFAT and, by direct interac-
tion with AP-1, also inhibits its transactivating function of these cells.
Immature DP thymocytes have been reported to un-(Towers et al., 1999). A requirement for both VDR and
RXR in vitamin D3-mediated inhibition of NFAT binding dergo two waves of TCR gene rearrangement and,
hence, need to survive long enough to assure that ifhas also been reported (Takeuchi et al., 1998). Although
ROR may also inhibit NFAT-responsive genes, this has they are not selected after the first rearrangement, they
have a second opportunity to be selected (Yannoutsosnot been demonstrated directly in untransfected cells
or in vivo, and may not be relevant in mature T cells, et al., 2001). It has been suggested that GR activation by
endogenous glucocorticoids provides the proapoptoticwhich do not appear to express ROR.
Biochemical studies on ROR have been limited, and stimulus in “death by neglect” of DP thymocytes. How-
ever, despite reduced dexamethasone-induced apopto-it remains unclear whether it functions as a monomer
or as a homo- or heterodimer. When tethered to a heter- sis in caspase-9 deficient mice, there was no evidence
of thymic hyperplasia (Kuida et al., 1998). Further studiesologous Gal4 DNA binding domain, ROR can activate
transcription, through recruitment of coactivators of the will need to be conducted, however, to determine if the
lifespan of thymocytes is affected in the absence ofp160 family (e.g., SRC-1) (Littman et al., 1999). It has
not been determined whether this interaction is ligand GR or of caspase-9. It has been postulated that, by
regulating Bcl-xL levels, ROR controls the timing forindependent and whether an N-terminal AF1 domain
or the C-terminal domain confers the transactivating survival and apoptosis of DP thymocytes (Sun et al.,
2000). Thymocytes that undergo positive selectionfunction. However, it appears that, similarly to the VDR,
ROR can function as a context-dependent transcrip- downregulate ROR and Bcl-xL, but upregulate Bcl-2,
which ensures their survival into mature T cells. Thosetional activator or repressor.
Analysis of mice in which the ROR gene was dis- cells that fail to be selected could die due to downregula-
tion of ROR or due to modulation in level of an RORrupted revealed significant roles of its product(s) in both
thymocyte development and in lymphoid organogenesis ligand.
There has not yet been any demonstration of target(Kurebayashi et al., 2000; Sun et al., 2000). In the thymus,
there was a profound reduction in the number of double- genes that are directly regulated by ROR in vivo. ROR
was shown to bind to a putative consensus motif in thepositive thymocytes, and consequently also a reduction
in mature thymocytes and T cells. This was due to a TEA element upstream of the J cluster in the TCR
locus (Villey et al., 1999). This element is required forsharply increased rate of apoptosis of double-positive
cells, which normally make up about 85% of total thymo- rearrangement of V segments to the 5 J segments.
Such rearrangements are favored early in development,cytes. The phenotype was observed even in the absence
of Fas-FasL interaction (in gld/gld mice) and there was and subsequent receptor editing in DP thymocytes is
thought to involve rearrangements to J segments lo-no change in the FasL expression level in thymocytes of
mutant mice, indicating that FasL is not a physiologically cated at 3 locations (Yannoutsos et al., 2001). It has
therefore been proposed that ROR may have a rolerelevant target of ROR in thymocytes. However, ROR
is required for expression of the antiapoptotic Bcl-xL in TEA element function, regulating the early wave of
rearrangements within the TCR locus. Analysis of themolecule in thymocytes. Both Bcl-xL mRNA and protein,
which are expressed at highest levels in DP thymocytes, TCR repertoire in ROR-deficient mice has not yet been
reported.were barely detectable in mice lacking ROR. It is not
yet known if Bcl-xL expression is under direct or indirect ROR has also been shown to be required for the
development of lymph nodes and Peyer’s patchesregulation by ROR. Absence of ROR also resulted in
reduction of p27kip1, and in subsequent unrestrained cell (Kurebayashi et al., 2000; Sun et al., 2000). In its absence,
there was loss of a population of embryonic cells with thecycle progression of double-positive thymocytes, with
a large proportion of the cells in S phase. This effect phenotype CD4CD3IL-7R47, which have been
proposed to be progenitor cells in lymph node develop-appears to be an indirect consequence of the reduction
in Bcl-xL in mutant mice since thymocyte cell numbers, ment (Sun et al., 2000). A similar phenotype of lymphoid
organ deficiency, including the loss of this specializedas well as p27kip1 expression, were restored by forced
expression of Bcl-xL (Sun et al., 2000). Studies have cell population, has been observed in mice lacking the
HLH inhibitory transcription factor Id2 (Yokota et al.,suggested that, in the thymus, activation of Cdk2, ac-
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1999). Both Id2 and RORare normally expressed in these a C-terminal ligand binding domain. The other family
members, Nor-1 (also called MINOR and 3 other names)putative progenitor cells, which also express lympho-
and Nurr1 (also called NOT, RNR1, TINOR, and TINUR),toxin (LT)- heterotrimers and TRANCE/RANKL, mem-
bear more than 90% homology in their DNA bindingbers of the TNF family (Kim et al., 2000; Mebius et al.,
domains but are divergent in their N- and C-terminal1997). Whereas LT and TRANCE are required for devel-
regions (Cheng et al., 1997). All three family membersopment of splenic follicles as well as lymph nodes and
can bind to a consensus NBRE sequence (AAAGGTCA)Peyer’s patches, the transcription factors ROR and Id2
as monomers or to a palindromic DNA binding motifare not required for development of the spleen. This
(NurRE, TGATATTTX6AAATGCCA) as homodimers (Phil-is consistent with a central role of splenic B cells in
ips et al., 1997). Expression of Nur77, Nor-1, or Nurr1production of LT, which is required for the formation of
alone is sufficient to activate NBRE or NurRE-directedthe follicular dendritic network (Fu and Chaplin, 1999).
transcriptional activities, suggesting that the Nur77 fam-The LT-expressing CD4 embryonic cells may therefore
ily members might be “constitutive” orphan steroid re-have a similar function in regulating the differentiation
ceptors that do not require ligands for activation. Inof the early lymph nodes and Peyer’s patches. Remark-
addition to its transcriptional function, Nur77 can alsoably, ROR is not required for the differentiation of nasal
act as a modulator of transcription for other orphanassociated lymphoid tissue (NALT), whose organization
steroid receptors. For example, Nur77 and Nurr1 canclosely resembles that of Peyer’s patches (Harmsen et
heterodimerize with RXR in the presence of retinoidsal., 2002). These findings indicate that the diverse
and modulate the activities of a subclass of retinoidlymphoid organs have different mechanisms of early
responsive elements (Forman et al., 1995; Perlmann anddifferentiation. All require expression of lymphotoxin
Jansson, 1995). Nur77 has also been reported to bindheterotrimers and triggering by the LT receptor of
and alter the activity of COUP-TF, an orphan steroidRelA-containing NF-B in cells reported to be radioresis-
receptor thought to negatively regulate the activationtant stromal cells (Alcamo et al., 2002), but different LT
function of vitamin D receptor, RAR, RXR, and PPARscell types migrate to specific sites to direct development
(Wu et al., 1997). Conversely, because of its interactionof each organ.
with RAR and RXR, Nur77 activity can be modulated
by natural and synthetic retinoic acids to influence cellThe Nur77 Family of Orphan Steroid Receptors
survival. All-trans or 9-cis-retinoic acids, which blockNur77 (also called TR3, NGFI-B, NAK1, and 8 other
AICD, also inhibit the transcriptional activity of Nur77aliases) is an inducible orphan nuclear receptor first
(and expression of FasL) in T cells (Kang et al., 2000;identified as an immediate early serum-induced gene
Toth et al., 2001). In contrast, CD437, a RAR-specific(Zhang et al., 1999), and subsequently as a gene induced
agonist, induces Nur77 expression through an unknownby T cell receptor (TCR) signaling in T cell hybridomas
mechanism and enhances Nur77-mediated NBRE activ-and thymocytes (Liu et al., 1994; Woronicz et al., 1994).
ity (Li et al., 1998; Toth et al., 2001). CD437 was shownIn contrast to GR and ROR, which are expressed in
to induce growth arrest and apoptosis of a variety ofresting cells and whose expression does not change
cancer cell lines in a p53-independent fashion. This apo-
appreciably in activated cells, Nur77 transcription is
ptotic activity was reported to be mediated through
controlled by external stimuli. Nur77 mRNA is upregu-
Nur77 (Li et al., 2000, 1998).
lated in both B and T lymphocytes following antigen
Nur77 is a phosphoprotein that typically migrates be-
receptor ligation, in fibroblasts in the presence of serum, tween 65 and 75 kDa. Phosphorylation of Nur77, which
and in nerve cells following their stimulation with nerve results in its predominant localization in the cytoplasm,
growth factor (NGF) or in response to seizures and me- can be carried out by several kinases. These include
chanical lesions (Liu et al., 1994; Mittelstadt and De- members of the MAP kinase family and the protein ki-
Franco, 1993; Woronicz et al., 1994). Interestingly, the nase Akt (Figure 2). Akt phosphorylates Nur77 in its DNA
kinetics of Nur77 induction in response to stimulation binding domain, resulting in reduced Nur77 DNA binding
by serum, NGF, or phorbol ester is transient and differs activity (Pekarsky et al., 2001). Overexpression of Akt
from that in T cells activated by TCR, in which induction reduces activation-induced cell death of T cell hybrido-
is long lasting. The functional significance of differential mas and can partially protect against wild-type Nur77-
kinetics of Nur77 induction is not well understood, but mediated apoptosis in Rat1a fibroblasts (Masuyama et
steady expression of Nur77 protein may induce apopto- al., 2001). In light of the fact that not all cell lines are
sis while transient expression does not. Indeed, consti- susceptible to Nur77-induced apoptosis, it will be inter-
tutive expression of Nur77 in thymocytes and in several esting to see if the activity of Akt correlates with resis-
cell lines leads to apoptosis (Calnan et al., 1995; Li et tance of cells to Nur77-mediated cell death.
al., 2000; Masuyama et al., 2001; Weih et al., 1996). In PC12 nerve cells, phosphorylation of Nur77 in its
However, the fact that Nur77 and its family members, N-terminal region by members of the MAP kinase family
Nor-1 and Nurr1, are expressed as immediate early regulates the ability of Nur77 to be exported to the cyto-
genes in different cell types following various stimuli, plasm in response to NGF (Katagiri et al., 2000). Stimula-
suggests that they play a role in a diverse set of biologi- tion of PC12 cells by NGF results in upregulation of
cal functions. Indeed, Nurr1-deficient mice lack mid- Nur77 protein and in its phosphorylation and subse-
brain dopaminergic neurons and die soon after birth quent translocation to the cytoplasm. Interestingly, RXR
(Zetterstrom et al., 1997). is also transported to the cytoplasm along with Nur77
Similar to other steroid receptor family members, through heterodimerization. Nur77 contains three nu-
Nur77 consists of an N-terminal AF1 transactivation do- clear export signals located in the “ligand binding” do-
main that, when mutated, cause Nur77 to remain in themain, a DNA binding domain with two zinc fingers, and
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Figure 2. A Schematic Diagram of Nur77 Signal Transduction
nucleus despite the presence of NGF (Katagiri et al., tion but positive selection proceeded normally (Calnan
et al., 1995; Zhou et al., 1996). Dominant-negative Nur772000). Mutating the MAP kinase serine phosphorylation
site of Nur77 to alanine also abolishes its growth factor- protein, however, has been shown to inhibit the activities
of all Nur77-related molecules (Cheng et al., 1997). Asinduced export from the nucleus. These data suggest
that NGF stimulation results in phosphorylation of the kinetics of Nor-1 expression in activated T cells
mirrors that of Nur77, Nor-1 is likely to share functionNur77, thus exposing the export signals within the
C-terminal ligand binding domain and causing translo- with Nur77 during T cell development (Cheng et al.,
1997). Similar to Nur77, constitutive Nor-1 expressioncation of Nur77 to the cytoplasm. Whether a similar
situation occurs in T cells or other immune cells has not leads to massive thymocyte cell death (Cheng et al.,
1997). Functional redundancy between Nur77 and itsbeen explored.
In T cells, Nur77 transcription triggered by TCR signal- related proteins might explain the complete lack of a
phenotype in Nur77-deficient mice (Lee et al., 1995).ing can be inhibited by cyclosporin A, suggesting that
calcineurin plays an important role in its regulation. Mi- Recently, mice deficient in PTEN, a known inhibitor of
Akt, were shown to be defective in negative selectioncroarray analyses have confirmed that transcripts for
Nur77 family members are rapidly upregulated in mature (Suzuki et al., 2001). Although not demonstrated directly,
this is consistent with an inhibitory role of Akt in theT cells stimulated with phorbol ester and ionomycin,
whereas they are not induced in T cells derived from regulation of Nur77, as discussed above. The function
of Nur77 and its family members has not yet been as-severe-combined immunodeficient patients with cal-
cium flux defects (Feske et al., 2001). Similarly, Nur77 sessed in mature T cells.
Nur77 transcription is regulated by a complex web ofand Nor-1 mRNAs/proteins were readily detectable in
thymocytes as early as 30 min after stimulation with transcription factors and other proteins (Figure 2). Using
promoter deletional analysis, two MEF2 binding sitesphorbol ester and ionomycin (Woronicz et al., 1995).
Maximal induction of Nur77 in CD4CD8 thymocytes were identified as TCR-regulated transcriptional ele-
ments in the Nur77 promoter region (Woronicz et al.,requires a signal through TCR and additional stimulation
through other cell surface proteins (Amsen et al., 1999). 1995). Interestingly, these MEF2 sites lie upstream and
are separated from transcriptional elements that are re-In contrast, molecules associated with positive selec-
tion or maturation of single positive (CD4CD8 or sponsive to serum and NGF stimulation (Williams and
Lau, 1993; Yoon and Lau, 1993). There are four MEF2CD4CD8) thymocytes, Egr-1, ERK2, and CD69, are
not affected by the costimulatory activities. While the family members: MEF2A, MEF2B, MEF2C, and MEF2D.
These transcription factors bear homology to the MADS-role of costimulatory molecules in negative selection in
vivo has not been clearly established, apoptosis of DP box proteins. Other than MEF2C, whose expression is
restricted to muscle and B cells, all other MEF2 familythymocytes in vitro requires combined signals from the
T cell receptor and additional molecules, including CD28 members are expressed widely. In T cells, MEF2D is the
dominant MEF2 family member. Expression and phos-(Kishimoto and Sprent, 1999). Consistent with these
data, transgenic mice expressing dominant-negative phorylation of the MEF2 proteins do not change upon
TCR stimulation. Recently, several repressors and acti-Nur77 were defective in the process of negative selec-
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vators were found to associate with MEF2D. In resting son et al., 2001; Li et al., 2000). The latter event causes
cells, Cabin-1, a calcineurin-interacting repressor pro- activation of Apaf-1 and caspase-9, followed by cleav-
tein, was found to associate with MEF2D (Youn and Liu, age of pro-caspase 3, leading to apoptosis (Li et al.,
2000; Youn et al., 1999). Overexpression of Cabin-1 in 1997). These experiments, done in prostate and lung
T cell hybridomas inhibited Nur77 induction and AICD cancer cell lines, showed that the Nur77 DNA binding
(Youn and Liu, 2000; Youn et al., 1999). In vivo, deletion domain is dispensable for this process. These data sug-
of the Cabin-1 C-terminal MEF2-interacting domain did gest that Nur77 transcription is not required for apopto-
not affect apoptosis or Nur77 expression but enhanced sis under these conditions. How Nur77 is translocated
cytokine production (Esau et al., 2001). The lack of an to mitochondria, however, is not clear, as Nur77 has
absolute requirement for Cabin-1 in repressing MEF2D- no mitochondrial targeting sequence. Similarly, it is not
dependent Nur77 expression may reflect the redundant understood how Nur77 causes cytochrome c release
function of other MEF2D interacting repressors. These into the cytoplasm. In T cell hybridomas, Nur77 is mostly
include the histone deacetylase HDAC4 (Miska et al., localized to the nucleus. Interestingly, overexpression
1999) and the HDAC-like protein MITR (Sparrow et al., of Bcl-2 does not block Nur77-mediated apoptosis in
1999). T cells (Zhang et al., 1999), suggesting that either Nur77
MEF2D is a weak transcription factor, and dissocia- transcription plays a more prominent role in initiating
tion of various repressors from MEF2D in activated apoptosis specifically in T cells or that Nur77 initiates
T cells is not sufficient to activate Nur77 transcription. a Bcl-2-independent mitochondrial apoptotic pathway.
NF-ATc1, through a DNA-independent mechanism, can Additional experiments are necessary to identify the
coactivate MEF2 DNA elements (Blaeser et al., 2000; Nur77 downstream target genes responsible for regulat-
Youn et al., 2000). In addition, ERK5, a kinase with a ing T cell apoptosis and to elucidate the mechanisms
unique C-terminal transcriptional activation domain, can of Nur77 localization to mitochondria in different cell
also associate with MEF2D and deliver a powerful tran- types.
scriptional activating activity (Kasler et al., 2000). ERK5
is the fourth class within the MAP kinase family and is Conclusions
activated by the upstream MEK5 kinase (Zhou et al., We have reviewed recent advances in understanding the
1995). MEK5 is in turn activated by MEKK2 or MEKK3
role of three members of the nuclear hormone receptor
kinases, depending on the stimuli (Chao et al., 1999).
superfamily in development and regulation of the im-
ERK5 activation, achieved by coexpression of an acti-
mune system. Although all of these receptors have been
vated form of MEK5 by expression of a truncated protein
implicated as having key roles in promoting either thy-
containing only the C-terminal region, can stimulate
mocyte survival or apoptosis, their in vivo functions have
Nur77 transcription in the absence of any TCR signaling
not yet been definitively characterized. Gene inactiva-(Kasler et al., 2000). Furthermore, a mutant form of ERK5
tion studies have not yet identified clear roles in thymo-that lacks the C-terminal transcriptional activation do-
cytes or in mature T cells for GR or for members of themain acts as a dominant-negative protein that sup-
Nur77 family, particularly Nor1, and generation of tissue-presses induction of Nur77 transcription (Kasler et al.,
specific gene targeted mice will be necessary to address2000). Thus, coordinated regulation through release of
their roles in the immune system. Targets for differentrepressors and simultaneous activation of coactivators
functions of these nuclear receptors also need to beconstitutes a mechanism whereby T cells can activate
identified. For the orphan steroid receptors, it is stillNur77 transcription to a high level in a relatively short
not clear if physiological ligands exist. Nevertheless,time.
identification and application of synthetic agonist or an-Few downstream genes for Nur77-mediated tran-
tagonist ligands could prove useful in clinical settingsscription have been identified. Although the expression
to modulate human immune responses and may leadlevels of FasL and CD30 are elevated in Nur77 transgenic
to useful therapeutic applications.mice (Weih et al., 1996; Zhang et al., 1999), Nur77-medi-
ated apoptosis is still intact in gld/gld (FasL mutant mice)
Acknowledgmentsor CD30/mice, precluding FasL and CD30 as the major
downstream effectors for Nur77 in thymocytes (Chan et
We thank Drs. Michael Garabedian, Frederic Geissmann, Arvind
al., 1998; Zhang et al., 1999). Consistent with this notion, Rajpal, Jyoti Sen, and Sue Sohn for their critical reading of this
negative selection of CD4CD8 (DP) thymocytes is in- manuscript.
tact in Fas- or CD30-deficient mice (DeYoung et al.,
2000; Singer and Abbas, 1994). In thymocytes, Nur77 References
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